Personalis Financial Activities - Other 2018-2024 | PSNL
Personalis financial activities - other from 2018 to 2024. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
Personalis Annual Financial Activities - Other
(Millions of US $) |
| 2024 |
$-1 |
| 2023 |
$N/A |
| 2022 |
$2 |
| 2021 |
$4 |
| 2020 |
$4 |
| 2019 |
$-4 |
| 2018 |
$0 |
| 2017 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.437B |
$0.085B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
